Skip to content

Evren Alici

  • MD, PhD
  • Group leader
  • Karolinska Institutet
  • 14h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 770CitationsNumber of citations received by Evren's publications. Updated daily.

Other IDs

Research interests

Cancer Cytogenetics Gene Therapy Immunotherapy Stem cell transplantation

About

Karolinska Institutet Stockholm, Sweden

Groups

Co-authors (31)

Publications (5)

  • Ex vivo expansion of natural killer cells: a question of function.

    • Sutlu T
    • Alici E
    N/AReaders
    N/ACitations
    Get full text
  • Clinical impact of chromosomal aberrations in multiple myeloma.

    • Nahi H
    • Sutlu T
    • Jansson M
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • GMP Facilities for Manufacturing of Advanced Therapy Medicinal Products for Clinical Trials: An Overview for Clinical Researchers

    • Alici E
    • Blomberg P
    N/AReaders
    N/ACitations
  • IPH-2101, a fully human anti-NK-cell inhibitory receptor mAb for the potential treatment of hematological cancers.

    • Alici E
    N/AReaders
    N/ACitations
  • Efficient gene transfer into primary human natural killer cells by retroviral transduction.

    • Guven H
    • Konstantinidis K
    • Alici E
    • et al.
    N/AReaders
    N/ACitations
    Get full text

Professional experience

Group leader

Karolinska Institutet

August 2008 - Present

Education

PhD

Karolinska Institutet

August 2002 - November 2006(4 years)

MD

Ege University faculty of medicine